Msn Pharmachem Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ATORVASTATIN CALCIUM USP (AMORPHOUS) [ROUTE CODE - "ACA"], with a corresponding US DMF Number 22785.
Remarkably, this DMF maintains an Active status since its submission on May 18, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2017, and payment made on August 22, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II